ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile.

CD47 is a widely expressed cell surface protein that functions as an immune checkpoint in cancer. When expressed by tumor cells, CD47 can bind SIRPα on myeloid cells, leading to suppression of tumor cell phagocytosis and other innate immune functions. CD47-SIRPα signaling has also been implicated in...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Steven E Kauder, Tracy C Kuo, Ons Harrabi, Amy Chen, Emma Sangalang, Laura Doyle, Sony S Rocha, Sangeetha Bollini, Bora Han, Janet Sim, Jaume Pons, Hong I Wan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2018-01-01
coleção:	PLoS ONE
Acesso em linha:	http://europepmc.org/articles/PMC6104973?pdf=render
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!